Your session is about to expire
← Back to Search
Keloid Revision Surgery with Biovance for Keloid Scars
Phase 4
Waitlist Available
Led By Dinakar Golla, MD
Research Sponsored by Golla Center for Plastic Surgery
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year post-surgery
Awards & highlights
Summary
The main purpose of this study is to see if there is clinical benefit of using Biovance in reduction of the recurrence of keloids when used to revise them. It will also assess the postoperative complications.
Eligible Conditions
- Keloid Scars
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year post-surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year post-surgery
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Incidence of keloid scar recurrence after revision surgery with placement of Biovance
Trial Design
1Treatment groups
Experimental Treatment
Group I: Keloid Revision Surgery with BiovanceExperimental Treatment1 Intervention
All enrolled patients will have Biovance applied during Keloid Revision Surgery
Find a Location
Who is running the clinical trial?
Golla Center for Plastic SurgeryLead Sponsor
Dinakar Golla, MDPrincipal InvestigatorGolla Center for Plastic Surgery
Share this study with friends
Copy Link
Messenger